Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Neothetics (NEOT)

Neothetics (NEOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Neothetics 9171 TOWNE CENTRE DRIVE SUITE 270 SAN DIEGO CA 92122 USA

www.neothetics.com P: 858-750-1008

Description:

Neothetics, Inc. is a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market. The Company is focused on localized fat reduction and body contouring. Its lead product candidate, LIPO-202, is for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients. The Company is also developing LIPO-102 for the treatment of the orphan indication of symptomatic exophthalmos, or protrusion of the eye from the orbit, associated with thyroid-related eye disease caused by the expansion of fat and muscle behind the eye. Neothetics, Inc. is headquartered in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 26,592
Shares Outstanding, K 13,850
Annual Sales, $ 0 K
Annual Net Income, $ -13,020 K
60-Month Beta 3.33
% of Insider Shareholders 39.20%
% of Institutional Shareholders 1.74%

Growth:

1-Year Return 62.71%
3-Year Return -71.30%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/09/17
Earnings Per Share ttm -0.55
EPS Growth vs. Prev Qtr 35.00%
EPS Growth vs. Prev Year 23.53%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 01/18/18

NEOT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -119.00%
Return-on-Assets % -101.14%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 5.49
Book Value/Share 0.00
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar